Eli Lilly (LLY) and Purdue University said Friday that the pharmaceuticals company plans to invest $250 million over eight years in a collaboration aimed primarily at finding and speeding delivery of new medicines..
The investment is an expansion to 2032 of an earlier agreement set to expire in 2027, the organizations said.
As part of the agreement, Purdue will offer space available for Lilly researchers in several Indiana facilities, the organizations said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.